Atezolizumab plus bevacizumab in Child-Pugh B advanced hepatocellular carcinoma patients

被引：5
|
作者：
Kim, Hyeyeong
Cheon, Jaekyung
Ha, Yeongjung
Kim, Han Sang
Kim, Chang Gon
Kim, Ilhwan
Kim, Chan
Jung, Sang-Hoon
Chon, Hong Jae
机构：
[1] Univ Ulsan, Ulsan Univ Hosp, Ulsan, South Korea
[2] CHA Bundang Med Ctr, Dept Med Oncol, Seongnam, South Korea
[3] CHA Bundang Med Ctr, Dept Gastroenterol, Seongnam, South Korea
[4] Yonsei Canc Ctr, Seoul, South Korea
[5] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Div Med Oncol,Dept Internal Med, Seoul, South Korea
[6] Inje Univ, Coll Med, Haeundae Paik Hosp, Dept Internal Med, Busan, South Korea
[7] CHA Bundang Med Ctr, Seongnam, South Korea
[8] CHA Bundang Med Ctr, Dept Radiol, Seongnam, South Korea
[9] CHA Bundang Med Ctr, Dept Med Oncol, Seongnam, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.397
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
397
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Atezolizumab plus bevacizumab in patients with child-Pugh B advanced hepatocellular carcinoma
    Cheon, Jaekyung
    Kim, Hyeyeong
    Kim, Han Sang
    Kim, Chang Gon
    Kim, Ilhwan
    Kang, Beodeul
    Kim, Chan
    Jung, Sanghoon
    Ha, Yeonjung
    Chon, Hong Jae
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [2] Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma
    Itoh, Shinji
    Ikeda, Masafumi
    HEPATOBILIARY SURGERY AND NUTRITION, 2022,
  • [3] Real-world use of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis
    D'Alessio, Antonio
    Weinmann, Arndt
    Galle, Peter R.
    Fulgenzi, Claudia Angela Maria
    Bettinger, Dominik
    Bengsch, Bertram
    Vogel, Arndt
    Balcar, Lorenz
    Scheiner, Bernhard
    Navaid, Musharraf
    Naqash, Abdul Rafeh
    Personeni, Nicola
    Pressiani, Tiziana
    Sharma, Rohini
    Pinter, Matthias
    Cortellini, Alessio
    Rimassa, Lorenza
    Pinato, David James
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [4] UNMET SYSTEMIC THERAPY NEED FOR CHILD-PUGH CLASS B PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA - COMPARISON OF ATEZOLIZUMAB PLUS BEVACIZUMAB AND LENVATINIB
    Ohama, Hideko
    Hiraoka, Atsushi
    Tada, Toshifumi
    Hirooka, Masashi
    Kariyama, Kazuya
    Itobayashi, Ei
    Kunihiko, Tsuji
    Ishikawa, Toru
    Toyoda, Hidenori
    Hatanaka, Takeshi
    Kakizaki, Satoru
    Naganuma, Atsushi
    Matono, Tomomitsu
    Tada, Fujimasa
    Nouso, Kazuhiro
    Hiasa, Yoichi
    Kumada, Takashi
    HEPATOLOGY, 2023, 78 : S1907 - S1907
  • [5] Efficacy and safety of atezolizumab and bevacizumab in the realworld treatment of Child Pugh B patients with advanced hepatocellular carcinoma
    Stella, Leonardo
    Ponziani, Francesca
    Santopaolo, Francesco
    Hollande, Clemence
    Gasbarrini, Antonio
    Sidali, Sabrina
    Pompili, Maurizio
    Bouattour, Mohamed
    JOURNAL OF HEPATOLOGY, 2023, 78 : S578 - S579
  • [6] Nivolumab for Child-Pugh B advanced hepatocellular carcinoma
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (08): : 614 - 614
  • [7] Feasibility of Gemcitabine plus Oxaliplatin in Advanced Hepatocellular Carcinoma Patients with Child-Pugh B Cirrhosis
    Dhooge, Marion
    Coriat, Romain
    Mir, Olivier
    Perkins, Geraldine
    Brezault, Catherine
    Boudou-Rouquette, Pascaline
    Goldwasser, Francois
    Chaussade, Stanislas
    ONCOLOGY, 2013, 84 (01) : 32 - 38
  • [8] Liver transplantation for advanced hepatocellular carcinoma in patients with Child-Pugh A and B
    Hammad, Ahmed
    Kaido, Toshimi
    Ogawa, Kohei
    Fujimoto, Yasuhiro
    Uemura, Tadahiro
    Mori, Akira
    Hatano, Etsuro
    Okajima, Hideaki
    Uemoto, Shinji
    SURGERY TODAY, 2016, 46 (02) : 248 - 254
  • [9] Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study
    D'Alessio, Antonio
    Fulgenzi, Claudia Angela Maria
    Nishida, Naoshi
    Schoenlein, Martin
    von Felden, Johann
    Schulze, Kornelius
    Wege, Henning
    Gaillard, Vincent E.
    Saeed, Anwaar
    Wietharn, Brooke
    Hildebrand, Hannah
    Wu, Linda
    Ang, Celina
    Marron, Thomas U.
    Weinmann, Arndt
    Galle, Peter R.
    Bettinger, Dominik
    Bengsch, Bertram
    Vogel, Arndt
    Balcar, Lorenz
    Scheiner, Bernhard
    Lee, Pei-Chang
    Huang, Yi-Hsiang
    Amara, Suneetha
    Muzaffar, Mahvish
    Naqash, Abdul Rafeh
    Cammarota, Antonella
    Personeni, Nicola
    Pressiani, Tiziana
    Sharma, Rohini
    Pinter, Matthias
    Cortellini, Alessio
    Kudo, Masatoshi
    Rimassa, Lorenza
    Pinato, David J.
    HEPATOLOGY, 2022, 76 (04) : 1000 - 1012
  • [10] PHASE I I STUDY OF ATEZOLIZUMAB PLUS BEVACIZUMAB COMBINATION THERAPY IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA AND CHILD-PUGH B: CHALLENGE TRIAL
    Terashima, Takeshi
    Ikeda, Masafumi
    Yamashita, Tatsuya
    Okusaka, Takuji
    Imaoka, Hiroshi
    Kobayashi, Satoshi
    Ogasawara, Sadahisa
    Kawaoka, Tomokazu
    Hiraoka, Atsushi
    Nakano, Masahito
    Nagashima, Fumio
    Sugimoto, Rie
    Moriguchi, Michihisa
    Inaba, Yoshitaka
    Shinoda, Satoru
    Ueno, Makoto
    Kato, Naoya
    Kudo, Masatoshi
    Furuse, Junji
    Nagano, Hiroaki
    HEPATOLOGY, 2024, 80
12345